Delivery Order SPE2DB22D2206-SPE2DB24FEV45

Award Date 12/27/23
Potential Completion Date 1/19/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The order is for the supply of BOSULIF 100 MG TABLET 120S, a pharmaceutical product, with a potential value of $9,982.56 and a completion date of March 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which...
This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The order, valued at $9,982.56, is for the supply of BOSULIF 100 MG TABLET 120S, a specialty pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which has a completion date of February 22, 2024. The contract...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $9,982.56 order is for the delivery of BOSULIF 100 MG TABLET 120S, a brand name pharmaceutical product, with a completion date of February 20, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA with a potential value of $999,999,999.00...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the provision of BOSULIF 500 MG TABLET 30S, a pharmaceutical product. The contract does not have a set-aside designation and has a potential value of $4,944.24. Amerisourcebergen Drug Corp is the prime contractor...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $10,955.43 firm fixed-price contract is for the supply of BOSULIF 400 MG TABLET 30S, a pharmaceutical product. The award has an ultimate completion date of August 29, 2024 and is not a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of prescription...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,047.42, is to deliver 120 units of the prescription drug BOSULIF 100 mg tablets. The award has an ultimate completion date of January 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4563925178 BOSULIF 100 MG TABLET 120S. The $4,991.27 contract has an ultimate completion date of April 1, 2024. AmerisourceBergen Drug Corp, a for-profit organization, is the prime contractor and serves as a key supplier of pharmaceuticals and medical supplies to the Department of Defense. The...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The order is for the supply of Bosulif 400 mg tablets, a specialty medication, at a firm fixed price of $21,910.86. The award is not associated with a set-aside program and has an ultimate completion date of September 18, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $9,982.56 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for BOSULIF 100 MG TABLET 120S, a pharmaceutical product. The contract has a completion date of March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $10,955.43 Firm Fixed Price Delivery Order is for the supply of 4564361948 - BOSULIF 400 MG TABLET 30S, with a completion date of May 13, 2024. Amerisourcebergen, a major pharmaceutical distribution company, is the prime contractor on this award. The company holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FEV45
    Delivery Order

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order, valued at $9,982.56, is for the supply of BOSULIF 100 MG TABLET 120S to support DLA Troop Support Medical programs. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of Defense. This delivery order does not have a set-aside designation and is scheduled for completion by January 19, 2024. Amerisourcebergen Drug Corp, as a prime contractor, has an established track record of supporting DLA's requirements for pharmaceuticals, medical supplies, and distribution services.

Generated 3/27/24, 10:39 AM